- Home
- FluxMPS™ Glasgow's Minimum Essential Medium (GMEM), High Glucose with Tryptose Phosphate Broth(TPB), 25mM HEPES: 1X Liquid
FluxMPS™ Glasgow's Minimum Essential Medium (GMEM), High Glucose with Tryptose Phosphate Broth(TPB), 25mM HEPES: 1X Liquid
FluxMPS™ DCP-GMEMH-N1X is a Microfluidics Suitable, quadruple-stage ultra-filtered (0.1 µm ×2 + 0.04 µm ×2) 1X liquid GMEM formulation supplemented with Tryptose Phosphate Broth (TPB) and 25 mM HEPES, engineered for organ-on-a-chip (OoC) and microphysiological system (MPS) platforms. The 0.04 µm final polish removes the sub-micron particulates and microaggregates that a conventional 0.22 µm filter passes through.
- High-glucose GMEM (4500 mg/L D-glucose) enriched with 25 mM HEPES and Tryptose Phosphate Broth for fastidious and demanding cell lines
- Quadruple-stage filtration train (0.1 µm ×2 + 0.04 µm ×2) reaching a 0.04 µm final pore-size polish
- Batch release specification: endotoxin < 0.05 EU/mL (LAL, USP <85>)
- Sodium bicarbonate (2750 mg/L) plus 25 mM HEPES co-buffering; approximately 7.2% CO2 required to hold pH 7.4
- Manufactured under an ISO 13485:2016 quality management system with full lot traceability
- 32 verified components with CAS traceability across inorganic salts, amino acids, vitamins and other additives
- Phenol red sodium salt (15 mg/L) included as a visual pH indicator — red-colored, clear solution
- Custom pH, glucose, HEPES and nutrient modifications available on request
- Formulation[+] L-Glutamine, [+] Sodium Bicarbonate, [+] Phenol Red, [+] HEPES, [+] Calcium, [+] Magnesium, [+] Glucose (High)
- Glucose4500.000 mg/L
- pH (USP <791>)7.4
- Osmolality (USP <785>)Contact for specification
- Endotoxin (USP <85>)< 0.05 EU/mL
- Filtration0.1 µm ×2 + 0.04 µm ×2
- Storage2–8°C, protect from light
- Shelf Life12 months from date of manufacture, unopened
- ShippingCold pack
- Sizes500 mL, 1000 mL
Engineered where standard media fails
Conventional 0.22 µm–filtered media passes mycoplasma-sized particles, subvisible particulates, and microaggregates that confound sensitive on-chip assays and foul microfluidic channels.
Microchannel-safe purity
0.04 µm final filtration; USP <788> Method 1 (light obscuration) particulate compliance. Formulated for particle-sensitive OoC microfluidic chips.
Total metabolic control
High-glucose GMEM base with defined L-glutamine, Tryptose Phosphate Broth and HEPES levels for precise control of carbon source and buffering in your experimental system.
Ultrapure-grade water
Type 1 water, 18.2 MΩ·cm resistivity (ASTM D1193 / ISO 3696). Low trace-metal and organic carbon (TOC) content minimizes uncontrolled variables in sensitive downstream assays.
Low background for imaging
Ultra-low particulate baseline supports confocal microscopy, biosensor measurement and live-cell imaging on-chip. Phenol red is present in this formulation for visual pH indication.
Rich, stable nutrient profile
32 verified ingredients per lot across inorganic salts, amino acids, vitamins, and other additives including Tryptose Phosphate Broth. Full CAS traceability, micro-batch precision manufacturing.
Customization on demand
pH, nutrient concentrations, HEPES level, and component modifications available. Contact support@diagnocine.com.
Quadruple-stage filtration system
Four serial filtration stages — two dedicated prefilter + final-filter pairs — reaching a final 0.04 µm polish under ISO Class 5 aseptic fill conditions.
-
1
0.1 µm Prefiltration I
Removes large aggregates, cell debris and protein precipitates; protects the downstream 0.04 µm final filter and extends its service life.
-
2
0.04 µm Final filtration I
First 0.04 µm pass; retains sub-micron particulates and microaggregates below the resolution of standard 0.22 µm filtration.
-
3
0.1 µm Prefiltration II
Second dedicated 0.1 µm mycoplasma-retentive grade prefilter, protecting the second 0.04 µm cartridge from bioburden and particulate loading.
-
4
0.04 µm Final filtration II — Polish
Ultimate 0.04 µm polishing filter; aseptic fill & finish in an ISO Class 5 (Class 100) environment. Final product QC release gate.
Performance vs. conventional media
FluxMPS™ DCP-GMEMH-N1X runs a repeated prefilter + final-filter pair, twice in series, reaching a 0.04 µm final cut-off with mycoplasma-retentive prefiltration at every production stage.
© Diagnocine® — DCP-GMEMH-N1X
OoC and MPS Applications
FluxMPS™ DCP-GMEMH-N1X delivers ultra-filtered, Microfluidics Suitable purity for organ-on-a-chip, microphysiological system and microfluidic applications requiring GMEM with Tryptose Phosphate Broth supplementation.
Automated Bioreactors & Robotics
An optional 0.01 µm (10 nm) ultra nano-filtered MPS Grade variant of this formulation is available on request for automated bioreactors and robotic perfusion systems.
- Total Particulate Exclusion: 0.01 µm filtration removes nanoparticulate aggregates that foul automated systems
- Valve & Sensor Protection: Reduces micro-fouling risk in automated perfusion and recirculation systems
- Extended Perfusion Stability: Consistent nutrient delivery over long-duration culture runs
Inquiry Required: Contact support@diagnocine.com to request the 0.01 µm MPS Grade variant.
Micro Physiological System (MPS) & Chip
0.04 µm filtered GMEM/TPB/HEPES formulation for organ-on-a-chip, tissue-on-a-chip and body-on-a-chip devices where particle-free media prevents channel fouling.
Cancer Cell Lines & Metabolic Research
High-glucose formulation supports Warburg-effect metabolic studies and glycolysis-dependent cancer cell line culture with precise carbon-source control.
iPSC-Derived Models
Ultra-clean base with Tryptose Phosphate Broth enrichment for iPSC differentiation protocols requiring defined, particulate-free media.
Endothelial & Primary Cells
Particle-free, TPB-enriched formulation for primary cells and endothelial monolayer studies on-chip.
Metabolic Flux Analysis
Defined high-glucose formulation for 13C isotope tracing and NMR metabolomics. Not compatible with Agilent Seahorse XF assays, which require bicarbonate-free, phenol red-free medium.
Microscopy & Optical Sensing
Ultra-low particulate background for confocal microscopy, biosensor measurements, and TEER monitoring on-chip.
Analytical release specifications
Every lot released against the full specification matrix. Certificate of Analysis available: support@diagnocine.com.
| Parameter | Specification |
|---|---|
| Formulation | [+] L-Glutamine, [+] Sodium Bicarbonate, [+] Phenol Red, [+] HEPES, [+] Calcium, [+] Magnesium, [+] Glucose (High, 4500 mg/L); also contains Tryptose Phosphate Broth |
| Appearance | Red-colored, clear solution |
| Total ingredients | 32 |
| pH USP <791> | 7.4 |
| Osmolality USP <785> | Contact for specification |
| Glucose | 4500.000 mg/L |
| Phenol Red | 15.000 mg/L (phenol red sodium salt) |
| Parameter | Specification |
|---|---|
| Endotoxin USP <85> BET | < 0.05 EU/mL (batch release specification) |
| Sterility USP <71> | No growth / 14 days |
| Mycoplasma | 0.1 µm mycoplasma-retentive filtration (not tested per lot) |
| Particulate ≥10 µm USP <788> Method 1 | NMT 25/mL |
| Particulate ≥25 µm USP <788> Method 1 | NMT 3/mL |
| Water purity | Type 1, 18.2 MΩ·cm |
| Manufacturing std. ISO | ISO 13485:2016 |
| Fill environment | ISO Class 5 (Class 100) |
| Parameter | Specification |
|---|---|
| Storage temperature | 2–8°C, protect from light |
| Freeze-thaw | Do not freeze |
| Shelf life | 12 months from date of manufacture, unopened |
| Shipping condition | Cold pack |
| CO2 requirement | Approximately 7.2% CO2 (calculated from 2750 mg/L NaHCO3 plus 25 mM HEPES co-buffering, target pH 7.4; validate per cell line and incubator set-point) |
| Parameter | Specification |
|---|---|
| Raw material grade | Reagent / cell culture grade |
| Traceability | Full lot traceability per ISO 13485 |
| Manufacturing QMS ISO | ISO 13485:2016 certified |
| UNSPSC | 41116155 — Molecular biology and cell culture growth media (UNv260801) |
| Regulatory alignment | 21 CFR Part 820 (QMSR) aligned |
| Production method | Micro-batch, per-lot QC release |
| Intended use | Research Use Only (RUO) |
Full composition (mg/L)
Glasgow's Minimum Essential Medium (GMEM), High Glucose with Tryptose Phosphate Broth, 25mM HEPES: 1X Liquid — 32 ingredients verified per lot with CAS numbers for raw-material traceability where known.
| Component | CAS Number | mg/L |
|---|---|---|
| INORGANIC SALTS | ||
| Calcium chloride dihydrate | 10035-04-8 | 265.000 |
| Ferric nitrate nonahydrate | 10421-48-4 | 0.100 |
| Magnesium sulfate anhydrous | 7487-88-9 | 97.720 |
| Potassium chloride | 7447-40-7 | 400.000 |
| Sodium bicarbonate | 144-55-8 | 2750.000 |
| Sodium chloride | 7647-14-5 | 6400.000 |
| Sodium dihydrogen phosphate anhydrous | 7558-80-7 | 109.000 |
| Component | CAS Number | mg/L |
|---|---|---|
| AMINO ACIDS | ||
| L-Arginine hydrochloride | 1119-34-2 | 42.000 |
| L-Cystine | 30925-07-6 | 24.000 |
| L-Glutamine | 56-85-9 | 292.000 |
| L-Histidine hydrochloride | 5934-29-2 | 21.000 |
| L-Isoleucine | 73-32-5 | 52.400 |
| L-Leucine | 61-90-5 | 52.400 |
| L-Lysine hydrochloride | 657-27-2 | 73.100 |
| L-Methionine | 63-68-3 | 15.000 |
| L-Phenylalanine | 63-91-2 | 33.000 |
| L-Threonine | 72-19-5 | 47.600 |
| L-Tryptophan | 73-22-3 | 8.000 |
| L-Tyrosine Disodium salt | 69847-45-6 | 52.000 |
| L-Valine | 72-18-4 | 46.800 |
| Component | CAS Number | mg/L |
|---|---|---|
| VITAMINS | ||
| Choline chloride | 67-48-1 | 2.000 |
| D-Ca-Pantothenate | 137-08-6 | 2.000 |
| Folic acid | 59-30-3 | 2.000 |
| Nicotinamide | 98-92-0 | 2.000 |
| Pyridoxal hydrochloride | 65-22-5 | 2.000 |
| Riboflavin | 83-88-5 | 0.200 |
| Thiamine hydrochloride | 67-03-8 | 2.000 |
| OTHERS | ||
| i-Inositol | 87-89-8 | 3.600 |
| D-Glucose | 50-99-7 | 4500.000 |
| HEPES buffer | 7365-45-9 | 5958.000 |
| Phenol red sodium salt | 34487-61-1 | 15.000 |
| Tryptose Phosphate Broth | 2950.000 | |
ISO 13485 Manufacturing & Compliance
Every batch of FluxMPS™ DCP-GMEMH-N1X is manufactured under a certified ISO 13485:2016 QMS with full lot traceability and multi-parameter QC release testing.
ISO 13485:2016 QMS
Full quality management system with documented procedures, deviation control, and CAPA. Every lot traceable from raw material to final release.
Ultrapure Type 1 Water
18.2 MΩ·cm resistivity (ASTM D1193 / ISO 3696 Type 1). Low trace-metal and TOC content controlled at the water-purification stage.
ISO Class 5 Fill & Finish
Final aseptic filling in an ISO Class 5 (Class 100) cleanroom. Immediate post-filtration fill to limit recontamination risk.
Micro-Batch Precision
Small-batch manufacturing with per-lot QC release. Each batch tested independently, not pooled or blended across lots.
Endotoxin USP <85> BET
LAL-based endotoxin test per manufacturing batch. Release specification: < 0.05 EU/mL — well below the levels reported to activate TLR4-mediated responses in sensitive immune cell assays.
Particulate USP <788> Method 1
Light obscuration particulate count. NMT 25/mL at ≥10 µm; NMT 3/mL at ≥25 µm per batch.
Osmolality USP <785>
Osmolality verified per lot using vapor pressure or freezing-point depression osmometry per USP <785>.
Documentation / CoA
Full Certificate of Analysis available per lot. Includes all QC parameters, test dates, and raw material lot numbers. Request: support@diagnocine.com.
- Endotoxin — LAL assay, USP <85> Bacterial Endotoxins Test; assay sensitivity 0.005 EU/mL; release specification < 0.05 EU/mL
- pH, osmolality, conductivity, appearance and clarity
- Sterility
How DCP-GMEMH-N1X compares
FluxMPS™ versus conventional 0.22 µm filtered media for OoC and MPS applications.
| Parameter | DCP-GMEMH-N1X (FluxMPS™) | Conventional 0.22 µm Filtered | Standard Alternative |
|---|---|---|---|
| Grade | Microfluidics Suitable | Standard grade | Standard grade |
| Formulation | [+] L-Glutamine, [+] Sodium Bicarbonate, [+] Phenol Red, [+] HEPES, [+] Calcium, [+] Magnesium, [+] Glucose (High) | Standard GMEM | Standard GMEM |
| Final filtration pore size | 0.04 µm | 0.22 µm | 0.22 µm |
| Number of filtration stages | 4 stages | 1 stage | 1–2 stages |
| Mycoplasma-retentive filtration | check_circle | cancel | cancel |
| Endotoxin (release specification) | < 0.05 EU/mL | Corning classical liquid media — < 0.25 EU/mL Sigma-Aldrich DMEM complete medium — ≤ 2 EU/mL Gibco classical DMEM — Not specified (recorded per lot) |
|
| USP particulate compliance | check_circle | cancel | cancel |
| Water quality | Type 1, 18.2 MΩ·cm | Type 2 typical | Type 2 typical |
| Manufacturing QMS | ISO 13485:2016 | ISO 9001 typical | Variable |
| Microfluidic channel compatibility | check_circle | cancel | cancel |
| Custom formulation | check_circle | cancel | Limited |
Comparison figures from published supplier specifications, accessed 2026-09-02. Suppliers that publish no numeric endotoxin specification are shown as "Not specified".
Frequently asked questions
Common questions about FluxMPS™ DCP-GMEMH-N1X and its use in OoC and MPS applications.
Supporting literature
Curated peer-reviewed references relevant to OoC/MPS applications and FluxMPS™ ultra-filtered cell culture media.
- Bhatia SN, Ingber DE. Microfluidic organs-on-chips. Nature Biotechnology. 2014;32(8):760–772.doi:10.1038/nbt.2989
- Sackmann EK, Fulton AL, Beebe DJ. The present and future role of microfluidics in biomedical research. Nature. 2014;507(7491):181–189.doi:10.1038/nature13118
- Huh D, et al. Reconstituting organ-level lung functions on a chip. Science. 2010;328(5986):1662–1668.doi:10.1126/science.1188302
- Ingber DE. Is it Time for Reviewer 3 to Request Human Organ Chip Experiments Instead of Animal Validation Studies? Advanced Science. 2020;7(22):2002162.doi:10.1002/advs.202002162
- Maoz BM, et al. A linked organ-on-chip model of the human neurovascular unit reveals the metabolic landscape of brain disease. Nature Biotechnology. 2018;36:865–874.doi:10.1038/nbt.4226
- Bhise NS, et al. A liver-on-a-chip platform with bioprinted hepatic spheroids. Biofabrication. 2016;8(1):014101.doi:10.1088/1758-5090/8/1/014101
- Luni C, Serena E, Elvassore N. Human-on-chip for therapy development and fundamental science. Current Opinion in Biotechnology. 2014;25:45–50.doi:10.1016/j.copbio.2013.08.015
- Erickson KA, Bhansali S. Mycoplasma contamination in cell cultures: a survey of incidence and approaches to prevention. Journal of the Association for Laboratory Automation. 2012;17(5):346–354.doi:10.1177/2211068212456089
- van Duinen V, et al. Microfluidic 3D cell culture: from tools to tissue models. Current Opinion in Biotechnology. 2015;35:118–126.doi:10.1016/j.copbio.2015.05.002
- Warburg O. On the origin of cancer cells. Science. 1956;123(3191):309–314.doi:10.1126/science.123.3191.309
